Rebates Would Be Limited By FDA Draft PBM Guidance, PCMA Argues
Executive Summary
"Performance based" or "sliding scale" rebates could be precluded by FDA's draft guidance on promotions by health care organizations and pharmacy benefits managers, the Pharmaceutical Care Management Association told FDA in April 6 comments.